Socioeconomic status plays a role in how strong the association is…. Previous studies have shown an association between working longer hours and risk factors that can contribute to type 2 diabetes incidence. These risk factors included physical inactivity, unhealthy lifestyle, poor nutritional choices, and cardiovascular disease. Other studies have …
Read More »Gestational Weight Gain Associated with Infant Birth Weight in Type 1 Diabetes Mothers
Maternal weight gain is key to controlling infant birth weight…. Infants born to mothers with pregestational diabetes are more likely to experience adverse outcomes, especially an increased birth weight. Previous studies have shown the importance of strict maternal glycemic control to prevent fetal hyperinsulinemia and accelerated growth. Excessive gestational …
Read More »Gastric Bypass Better than Gastric Band for Long-Term Results
Gastric bypass surgery shows better outcomes for long-term weight loss, controlling type 2 diabetes, hypertension, and cholesterol level…. Puzziferri and colleagues conducted a clinical review of 29 studies (7,971 patients) looking at outcomes of gastric bypass, gastric band or sleeve gastrectomy on patients with BMI ≥35 at 1 year …
Read More »Adding an SGLT2 to Insulin Improved Control
Adding an SGLT2 inhibitor to multiple daily doses of insulin improved glycemic control, benefited weight loss, lowered insulin doses, and no increase in hypoglycemia was seen… Some patients with inadequately controlled type 2 diabetes still do not achieve glycemic control with multiple daily doses of insulin. Empagliflozin is a …
Read More »Healthy Lifestyle Lowers Risk for Gestational Diabetes by 52%
Adherence to healthy lifestyle during pregnancy is associated with a lower risk of gestational diabetes…. In a prospective cohort study, researchers looked at data on 14,437 women who participated in the Nurses’ Health Study II. Data was collected from the years of 1989-2001. Participants were aged 24 to 44 …
Read More »SGLT-2 Inhibitor May Reduce Blood Pressure for Type 2s
SGLT-2 inhibitor use in the management of glucose in type 2 diabetes could reduce blood pressure in patients with hypertension…. In a new study, researchers found that empagliflozin lowered blood pressure in patients with type 2 diabetes and hypertension. Hypertension affects about two-thirds of patients with diabetes. See more …
Read More »African-Americans More Likely to Have Amputations
Black Americans on Medicare are three times more likely than other patients to lose a leg to amputation because of complications with diabetes and peripheral arterial disease…. Even low-risk black patients with diabetes and peripheral arterial disease faced a higher risk of amputation than most nonblack patients, according to a …
Read More »“Millennial” Age Group Concerned about Managing Their Diabetes
However, older diabetes patients have a more serious attitude towards their disease….
Read More »Potential of SGLT2 Inhibitors in Type 1 Diabetes
Pilot study shows that an SGLT-2 inhibitor doses of 5-mg and 10-mg were associated with significant reductions in blood glucose and total daily insulin dose…. Dapagliflozin is a member of the SGLT2 inhibitor class of diabetic medications indicated only for treatment of type 2 diabetes. Dapagliflozin helps reduce blood glucose …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #13: Control and Complications
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Much of the impact of chronic diabetes results from the development of tissue complications, mainly microvascular (retinopathy, nephropathy and neuropathy) and macrovascular disease (atherosclerosis). Microangiopathy is characterized by progressive occlusion of the capillary lumen with subsequent impaired tissue perfusion, increased vascular …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.